Do you want to read an article? Please log in or register.
Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Lancet Gastroenterol Hepatol.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group
doi: 10.1016/S2468-1253(19)30012-3.
Celiac DiseaseGastrointestinal DiseasesGastritisGastroesophageal Reflux Disease (GERD)Minimally Invasive Gastrointestinal SurgeryFurther Publications
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
PloS One.
Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, Scharl M, Greuter T, Schreiner P, Frei P, Misselwitz B, Biedermann L, Zeitz J, Swiss IBD Cohort Study Group.
doi: 10.1371/journal.
Inflammatory Bowel Disease
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors-Results from the Swiss IBD Cohort Study
Am J Gastroenterol.
Scharl S, Barthel C, Rossel JB, Biedermann L, Misselwitz B, Schoepfer AM, Straumann A, Vavricka SR, Rogler G, Scharl M, Greuter T
doi: 10.1038/s41395-018-0360-9.
Inflammatory Bowel Disease
Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort
Eur J Gastroenterol Hepatol.
Godat S, Fournier N, Safroneeva E, Juillerat P, Nydegger A, Straumann A, Vavricka S, Biedermann L, Greuter T, Fraga M, Abdelrahman K, Hahnloser D, Sauter B, Rogler G, Michetti P, Schoepfer AM, Swiss IBD Cohort Study Group
doi: 10.1097/MEG.
COMMENTED
Inflammatory Bowel Disease
Genetic risk factors predict disease progression in Crohn's disease patients of the Swiss inflammatory bowel disease cohort
★ 2
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Therap Adv Gastroenterol
Ditrich F, Blümel S, Biedermann L, Fournier N, Rossel JB, Ellinghaus D, Franke A, Stange EF, Rogler G, Scharl M, Swiss IBD Cohort Study Group.
doi: 10.1177/1756284820959252
Inflammatory Bowel Disease
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study
PLoS One.
Roth N, Biedermann L, Fournier N, Butter M, Vavricka SR, Navarini AA, Rogler G, Scharl M; Swiss IBD Cohort Study Group
doi: 10.1371/journal.pone.0210436.
Inflammatory Bowel Disease
A Population-Based Study of Combination vs Monotherapy of Anti-TNF in Persons With IBD
Inflamm Bowel Dis.
Elias ED, Targownik LE, Singh H, Bernstein CN
doi: 10.1093/ibd/izz148.
Inflammatory Bowel Disease
Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study
J Crohns Colitis.
Parragi L, Fournier N, Zeitz J, Scharl M, Greuter T, Schreiner P, Misselwitz B, Safroneeva E, Schoepfer AM, Vavricka SR, Rogler G, Biedermann L; Swiss IBD Cohort Study Group
doi: 10.1093/ecco-jcc/jjy040.
Inflammatory Bowel Disease
Adherence to a Mediterranean diet is associated with a lower risk of later-onset Crohn's disease: results from two large prospective cohort studies
Gut.
Khalili H, Håkansson N, Chan SS, Chen Y, Lochhead P, Ludvigsson JF, Chan AT, Hart AR, Olén O, Wolk A
doi: 10.1136/gutjnl-2019-319505.